Prelude Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,471
| Closed | -$214K | – | 1374 |
|
|
2024
Q2 | $214K | Sell |
12,471
-19,016
| -60% | -$326K | 0.01% | 879 |
|
|
2024
Q1 | $492K | Buy |
+31,487
| New | +$492K | 0.03% | 569 |
|
|
2021
Q3 | – | Sell |
-1,397
| Closed | -$310K | – | 1608 |
|
|
2021
Q2 | $310K | Sell |
1,397
-123
| -8% | -$27.3K | 0.01% | 947 |
|
|
2021
Q1 | $201K | Buy |
+1,520
| New | +$201K | 0.01% | 928 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1311 |
|
|
2020
Q3 | – | Sell |
-1,236
| Closed | -$73K | – | 1697 |
|
|
2020
Q2 | $73K | Buy |
+1,236
| New | +$73K | ﹤0.01% | 725 |
|
|
2019
Q2 | – | Sell |
-23,403
| Closed | -$1.13M | – | 1577 |
|
|
2019
Q1 | $1.13M | Sell |
23,403
-1,812
| -7% | -$87.3K | 0.06% | 145 |
|
|
2018
Q4 | $844K | Sell |
25,215
-1,154
| -4% | -$38.6K | 0.06% | 219 |
|
|
2018
Q3 | $1.38M | Sell |
26,369
-265
| -1% | -$13.9K | 0.08% | 176 |
|
|
2018
Q2 | $834K | Buy |
26,634
+2,121
| +9% | +$66.4K | 0.05% | 282 |
|
|
2018
Q1 | $534K | Sell |
24,513
-2,121
| -8% | -$46.2K | 0.04% | 367 |
|
|
2017
Q4 | $538K | Buy |
26,634
+17,173
| +182% | +$347K | 0.04% | 353 |
|
|
2017
Q3 | $188K | Buy |
+9,461
| New | +$188K | 0.02% | 611 |
|
|
2016
Q4 | – | Sell |
-39,483
| Closed | -$337K | – | 1652 |
|
|
2016
Q3 | $337K | Buy |
+39,483
| New | +$337K | 0.04% | 353 |
|